APO Research
Talk to an analyst

APO RESEARCH · REPORT

Urticaria Drug

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Urticaria Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025183 pages

Choose your research edition.

Industry ResearchUrticaria Drug Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Urticaria Drug Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Urticaria Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Urticaria Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Urticaria Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Urticaria Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Urticaria Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Urticaria Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Urticaria Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Urticaria Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Urticaria Drug include Akorn, Amneal Pharmaceuticals, Genentech, Taro Pharmaceutical Industries Novartis AG, Xolair, Pfizer, Johnson and Johnson Services and Teva Pharmaceutical Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Urticaria Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Urticaria Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Urticaria Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Urticaria Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

Urticaria Drug Segment by Company

Akorn

Amneal Pharmaceuticals

Genentech

Taro Pharmaceutical Industries Novartis AG

Xolair

Pfizer

Johnson and Johnson Services

Teva Pharmaceutical Industries

Urticaria Drug Segment by Type

Acute Urticaria

Chronic Urticaria

Urticaria Drug Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Others

Urticaria Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urticaria Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Urticaria Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urticaria Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Urticaria Drug market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Urticaria Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Urticaria Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Urticaria Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Urticaria Drug Industry Trends Table 2. Urticaria Drug Industry Drivers Table 3. Urticaria Drug Industry Opportunities and Challenges Table 4. Urticaria Drug Industry Restraints Table 5. Global Urticaria Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Urticaria Drug Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Urticaria Drug Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Urticaria Drug Sales Market Share by Manufacturers Table 9. Global Urticaria Drug Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Urticaria Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Urticaria Drug Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Urticaria Drug Manufacturers, Product Type & Application Table 13. Global Urticaria Drug Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Urticaria Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Acute Urticaria Table 17. Major Manufacturers of Chronic Urticaria Table 18. Global Urticaria Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 19. Global Urticaria Drug Sales by Type (2021-2026) & (K Units) Table 20. Global Urticaria Drug Sales by Type (2027-2032) & (K Units) Table 21. Global Urticaria Drug Sales Market Share by Type (2021-2026) Table 22. Global Urticaria Drug Sales Market Share by Type (2027-2032) Table 23. Global Urticaria Drug Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 24. Global Urticaria Drug Revenue by Type (2021-2026) & (K Units) Table 25. Global Urticaria Drug Revenue by Type (2027-2032) & (K Units) Table 26. Global Urticaria Drug Revenue Market Share by Type (2021-2026) Table 27. Global Urticaria Drug Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Retail Pharmacies Table 29. Major Manufacturers of Online Pharmacies Table 30. Major Manufacturers of Hospital Pharmacies Table 31. Major Manufacturers of Others Table 32. Global Urticaria Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Urticaria Drug Sales by Application (2021-2026) & (K Units) Table 34. Global Urticaria Drug Sales by Application (2027-2032) & (K Units) Table 35. Global Urticaria Drug Sales Market Share by Application (2021-2026) Table 36. Global Urticaria Drug Sales Market Share by Application (2027-2032) Table 37. Global Urticaria Drug Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global Urticaria Drug Revenue by Application (2021-2026) & (K Units) Table 39. Global Urticaria Drug Revenue by Application (2027-2032) & (K Units) Table 40. Global Urticaria Drug Revenue Market Share by Application (2021-2026) Table 41. Global Urticaria Drug Revenue Market Share by Application (2027-2032) Table 42. Global Urticaria Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Urticaria Drug Sales by Region (2021-2026) & (K Units) Table 44. Global Urticaria Drug Sales Market Share by Region (2021-2026) Table 45. Global Urticaria Drug Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global Urticaria Drug Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Urticaria Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America Urticaria Drug Sales by Country (2021-2026) & (K Units) Table 49. North America Urticaria Drug Sales by Country (2027-2032) & (K Units) Table 50. Europe Urticaria Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe Urticaria Drug Sales by Country (2021-2026) & (K Units) Table 52. Europe Urticaria Drug Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific Urticaria Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific Urticaria Drug Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific Urticaria Drug Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa Urticaria Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa Urticaria Drug Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa Urticaria Drug Sales by Country (2027-2032) & (K Units) Table 59. Global Urticaria Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Urticaria Drug Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Urticaria Drug Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Urticaria Drug Revenue Market Share by Region (2021-2026) Table 63. Global Urticaria Drug Revenue Market Share by Region (2027-2032) Table 64. Akorn Company Information Table 65. Akorn Business Overview Table 66. Akorn Urticaria Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Akorn Urticaria Drug Product Portfolio Table 68. Akorn Recent Development Table 69. Amneal Pharmaceuticals Company Information Table 70. Amneal Pharmaceuticals Business Overview Table 71. Amneal Pharmaceuticals Urticaria Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Amneal Pharmaceuticals Urticaria Drug Product Portfolio Table 73. Amneal Pharmaceuticals Recent Development Table 74. Genentech Company Information Table 75. Genentech Business Overview Table 76. Genentech Urticaria Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Genentech Urticaria Drug Product Portfolio Table 78. Genentech Recent Development Table 79. Taro Pharmaceutical Industries Novartis AG Company Information Table 80. Taro Pharmaceutical Industries Novartis AG Business Overview Table 81. Taro Pharmaceutical Industries Novartis AG Urticaria Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Taro Pharmaceutical Industries Novartis AG Urticaria Drug Product Portfolio Table 83. Taro Pharmaceutical Industries Novartis AG Recent Development Table 84. Xolair Company Information Table 85. Xolair Business Overview Table 86. Xolair Urticaria Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Xolair Urticaria Drug Product Portfolio Table 88. Xolair Recent Development Table 89. Pfizer Company Information Table 90. Pfizer Business Overview Table 91. Pfizer Urticaria Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Pfizer Urticaria Drug Product Portfolio Table 93. Pfizer Recent Development Table 94. Johnson and Johnson Services Company Information Table 95. Johnson and Johnson Services Business Overview Table 96. Johnson and Johnson Services Urticaria Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Johnson and Johnson Services Urticaria Drug Product Portfolio Table 98. Johnson and Johnson Services Recent Development Table 99. Teva Pharmaceutical Industries Company Information Table 100. Teva Pharmaceutical Industries Business Overview Table 101. Teva Pharmaceutical Industries Urticaria Drug Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Teva Pharmaceutical Industries Urticaria Drug Product Portfolio Table 103. Teva Pharmaceutical Industries Recent Development Table 104. Key Raw Materials Table 105. Raw Materials Key Suppliers Table 106. Urticaria Drug Distributors List Table 107. Urticaria Drug Customers List Table 108. Research Programs/Design for This Report Table 109. Authors List of This Report Table 110. Secondary Sources Table 111. Primary Sources List of Figures Figure 1. Urticaria Drug Product Image Figure 2. Global Urticaria Drug Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Urticaria Drug Market Size (2021-2032) & (US$ Million) Figure 4. Global Urticaria Drug Sales (2021-2032) & (K Units) Figure 5. Global Urticaria Drug Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Urticaria Drug Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Acute Urticaria Image Figure 9. Chronic Urticaria Image Figure 10. Global Urticaria Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 11. Global Urticaria Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Urticaria Drug Sales Market Share by Type (2021-2032) Figure 13. Global Urticaria Drug Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 14. Global Urticaria Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Urticaria Drug Revenue Market Share by Type (2021-2032) Figure 16. Retail Pharmacies Image Figure 17. Online Pharmacies Image Figure 18. Hospital Pharmacies Image Figure 19. Others Image Figure 20. Global Urticaria Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Urticaria Drug Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Urticaria Drug Sales Market Share by Application (2021-2032) Figure 23. Global Urticaria Drug Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global Urticaria Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Urticaria Drug Revenue Market Share by Application (2021-2032) Figure 26. North America Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America Urticaria Drug Sales Market Share by Country (2021-2032) Figure 28. U.S. Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe Urticaria Drug Sales Market Share by Country (2021-2032) Figure 33. Germany Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific Urticaria Drug Sales Market Share by Country (2021-2032) Figure 40. China Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa Urticaria Drug Sales Market Share by Country (2021-2032) Figure 48. Brazil Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile Urticaria Drug Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global Urticaria Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Urticaria Drug Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Urticaria Drug Revenue (2021-2032) & (US$ Million) Figure 59. North America Urticaria Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Urticaria Drug Revenue (2021-2032) & (US$ Million) Figure 61. Europe Urticaria Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Urticaria Drug Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Urticaria Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Urticaria Drug Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Urticaria Drug Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Urticaria Drug Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Urticaria Drug Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Acute Urticaria
  • Chronic Urticaria
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
  • Others
Companies covered
  • Akorn
  • Amneal Pharmaceuticals
  • Genentech
  • Taro Pharmaceutical Industries Novartis AG
  • Xolair
  • Pfizer
  • Johnson and Johnson Services
  • Teva Pharmaceutical Industries

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Urticaria Drug Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Urticaria Drug Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Urticaria Drug Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Urticaria Drug Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Urticaria Drug Market Dynamics
  1. 2.1 Urticaria Drug Industry Trends
  2. 2.2 Urticaria Drug Industry Drivers
  3. 2.3 Urticaria Drug Industry Opportunities and Challenges
  4. 2.4 Urticaria Drug Industry Restraints
3 Urticaria Drug Market by Manufacturers
  1. 3.1 Global Urticaria Drug Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Urticaria Drug Sales by Manufacturers (2021-2026)
  3. 3.3 Global Urticaria Drug Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Urticaria Drug Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Urticaria Drug Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Urticaria Drug Manufacturers, Product Type & Application
  7. 3.7 Global Urticaria Drug Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Urticaria Drug Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Urticaria Drug Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Urticaria Drug Tier 1, Tier 2, and Tier 3
4 Urticaria Drug Market by Type
  1. 4.1 Urticaria Drug Type Introduction
  2. 4.1.1 Acute Urticaria
  3. 4.1.2 Chronic Urticaria
  4. 4.2 Global Urticaria Drug Sales by Type
  5. 4.2.1 Global Urticaria Drug Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Urticaria Drug Sales by Type (2021-2032)
  7. 4.2.3 Global Urticaria Drug Sales Market Share by Type (2021-2032)
  8. 4.3 Global Urticaria Drug Revenue by Type
  9. 4.3.1 Global Urticaria Drug Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Urticaria Drug Revenue by Type (2021-2032)
  11. 4.3.3 Global Urticaria Drug Revenue Market Share by Type (2021-2032)
5 Urticaria Drug Market by Application
  1. 5.1 Urticaria Drug Application Introduction
  2. 5.1.1 Retail Pharmacies
  3. 5.1.2 Online Pharmacies
  4. 5.1.3 Hospital Pharmacies
  5. 5.1.4 Others
  6. 5.2 Global Urticaria Drug Sales by Application
  7. 5.2.1 Global Urticaria Drug Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Urticaria Drug Sales by Application (2021-2032)
  9. 5.2.3 Global Urticaria Drug Sales Market Share by Application (2021-2032)
  10. 5.3 Global Urticaria Drug Revenue by Application
  11. 5.3.1 Global Urticaria Drug Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Urticaria Drug Revenue by Application (2021-2032)
  13. 5.3.3 Global Urticaria Drug Revenue Market Share by Application (2021-2032)
6 Global Urticaria Drug Sales by Region
  1. 6.1 Global Urticaria Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Urticaria Drug Sales by Region (2021-2032)
  3. 6.2.1 Global Urticaria Drug Sales by Region (2021-2026)
  4. 6.2.2 Global Urticaria Drug Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Urticaria Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Urticaria Drug Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Urticaria Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Urticaria Drug Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Urticaria Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Urticaria Drug Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Urticaria Drug Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Urticaria Drug Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Urticaria Drug Revenue by Region
  1. 7.1 Global Urticaria Drug Revenue by Region
  2. 7.1.1 Global Urticaria Drug Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Urticaria Drug Revenue by Region (2021-2026)
  4. 7.1.3 Global Urticaria Drug Revenue by Region (2027-2032)
  5. 7.1.4 Global Urticaria Drug Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Urticaria Drug Revenue (2021-2032)
  8. 7.2.2 North America Urticaria Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Urticaria Drug Revenue (2021-2032)
  11. 7.3.2 Europe Urticaria Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Urticaria Drug Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Urticaria Drug Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Urticaria Drug Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Urticaria Drug Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Akorn
  2. 8.1.1 Akorn Company Information
  3. 8.1.2 Akorn Business Overview
  4. 8.1.3 Akorn Urticaria Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Akorn Urticaria Drug Product Portfolio
  6. 8.1.5 Akorn Recent Developments
  7. 8.2 Amneal Pharmaceuticals
  8. 8.2.1 Amneal Pharmaceuticals Company Information
  9. 8.2.2 Amneal Pharmaceuticals Business Overview
  10. 8.2.3 Amneal Pharmaceuticals Urticaria Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Amneal Pharmaceuticals Urticaria Drug Product Portfolio
  12. 8.2.5 Amneal Pharmaceuticals Recent Developments
  13. 8.3 Genentech
  14. 8.3.1 Genentech Company Information
  15. 8.3.2 Genentech Business Overview
  16. 8.3.3 Genentech Urticaria Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Genentech Urticaria Drug Product Portfolio
  18. 8.3.5 Genentech Recent Developments
  19. 8.4 Taro Pharmaceutical Industries Novartis AG
  20. 8.4.1 Taro Pharmaceutical Industries Novartis AG Company Information
  21. 8.4.2 Taro Pharmaceutical Industries Novartis AG Business Overview
  22. 8.4.3 Taro Pharmaceutical Industries Novartis AG Urticaria Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Taro Pharmaceutical Industries Novartis AG Urticaria Drug Product Portfolio
  24. 8.4.5 Taro Pharmaceutical Industries Novartis AG Recent Developments
  25. 8.5 Xolair
  26. 8.5.1 Xolair Company Information
  27. 8.5.2 Xolair Business Overview
  28. 8.5.3 Xolair Urticaria Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Xolair Urticaria Drug Product Portfolio
  30. 8.5.5 Xolair Recent Developments
  31. 8.6 Pfizer
  32. 8.6.1 Pfizer Company Information
  33. 8.6.2 Pfizer Business Overview
  34. 8.6.3 Pfizer Urticaria Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Pfizer Urticaria Drug Product Portfolio
  36. 8.6.5 Pfizer Recent Developments
  37. 8.7 Johnson and Johnson Services
  38. 8.7.1 Johnson and Johnson Services Company Information
  39. 8.7.2 Johnson and Johnson Services Business Overview
  40. 8.7.3 Johnson and Johnson Services Urticaria Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Johnson and Johnson Services Urticaria Drug Product Portfolio
  42. 8.7.5 Johnson and Johnson Services Recent Developments
  43. 8.8 Teva Pharmaceutical Industries
  44. 8.8.1 Teva Pharmaceutical Industries Company Information
  45. 8.8.2 Teva Pharmaceutical Industries Business Overview
  46. 8.8.3 Teva Pharmaceutical Industries Urticaria Drug Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Teva Pharmaceutical Industries Urticaria Drug Product Portfolio
  48. 8.8.5 Teva Pharmaceutical Industries Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Urticaria Drug Value Chain Analysis
  2. 9.1.1 Urticaria Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Urticaria Drug Production Mode & Process
  6. 9.2 Urticaria Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Urticaria Drug Distributors
  9. 9.2.3 Urticaria Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst